Aortic stiffness, left ventricular hypertrophy and weekly average

Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure (WAB) in patients on haemodialysis. Nephrol Dial Transplant. 2007;22:1198–204.PubMedCrossRef 22. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, et al. Nocturnal blood

pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–91.PubMedCrossRef 23. Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Lazertinib concentration Mallamaci F, Buoncristiani U, et al. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int. 2005;68:1294–302.PubMedCrossRef 24. Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake BIX 1294 chemical structure T, et al. Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol. 2008;3:416–22.PubMedCrossRef 25. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt

WC, Peterson D, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54:561–9.PubMedCrossRef 26. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara AC220 order H, Shiohira Y, et al. Low diastolic blood pressure, hypoalbuminemia and risk of death in a cohort of chronic hemodialysis patients. Kidney Int. 1997;51:1212–7.PubMedCrossRef 27. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999;33:507–17.PubMedCrossRef 28. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793–808.PubMedCrossRef 29. Lopes AA, Bragg-Gresham JL, Ramirez Oxaprozin SP, Andreucci VE, Akiba T, Saito A, et al. Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics,

country and survival in the DOPPS. Nephrol Dial Transplant. 2009;24:2809–16.PubMedCrossRef 30. Metoki H, Ohkubo T, Imai Y. Diurnal blood pressure variation and cardiovascular prognosis in a community-based study of Ohasama, Japan; diurnal variations in blood pressure: clinical implications and pathogenesis. Hypertens Res. 2010;33:652–6.PubMedCrossRef”
“Introduction Klotho has been investigated as an anti-aging protein that is predominantly expressed in the distal convoluted tubules in the kidney and in the choroid plexus of the brain, although the expression level of Klotho is higher in the kidneys [1]. The klotho gene encodes a single-pass transmembrane protein with a long extracellular domain and a short cytoplasmic tail that functions as a co-receptor for fibroblast growth factor-23 (FGF23) and plays a role in phosphate metabolism [2].

Comments are closed.